CONTEXT AND OBJECTIVES

​

Health is constantly evolving with new technologies, digital and data. The pharmaceutical industry must adapt its research & development department, discover new targets, accelerate the development to be more competitive, access the market and finally reach patients. The requirements are evolving and the pharmaceutical industry must understand them to enable future success.

​

Also, chemistry and biology have only allowed to identify a small part of the therapeutic possibilities. The arrival of data and AI has opened a whole new field of approaches.

​

Algorithms will contribute and are already contributing to tomorrow’s health through more efficient medical practices, better analysis of active ingredients and lower costs. It also allows a rapid synthesis of empirical knowledge and represents a support for personalized medicine and diagnosis.

​

The objectives of this study are:

​

• Map and assess the main partnerships, collaborations, or innovations in the field of digital health

• Get an overview of the key innovations depending of the life cycle management

​

What you will find in this study:

​

• The main partnerships, collaborations, exclusive relations, innovations in the field of digital health

• An overview of the key innovations across the life cycle management